Thus, we confirm that UCHL3 is a deubiquitinase for JAK2-phosphorylated BRD4, whose overexpression in CRC may provide a mechanism to maintain the BRD4 protein abundance in an inflammatory tumor microenvironment. The gene discussed is JAK2; the disease is neoplasm.